Literature DB >> 21281018

Agathisflavone enhances retinoic acid-induced neurogenesis and its receptors α and β in pluripotent stem cells.

Bruna S Paulsen1, Cleide S Souza, Leonardo Chicaybam, Martin Hernán Bonamino, Marcus Bahia, Silvia Lima Costa, Helena L Borges, Stevens K Rehen.   

Abstract

Flavonoids have key functions in the regulation of multiple cellular processes; however, their effects have been poorly examined in pluripotent stem cells. Here, we tested the hypothesis that neurogenesis induced by all-trans retinoic acid (RA) is enhanced by agathisflavone (FAB, Caesalpinia pyramidalis Tull). Mouse embryonic stem (mES) cells and induced pluripotent stem (miPS) cells growing as embryoid bodies (EBs) for 4 days were treated with FAB (60 μM) and/or RA (2 μM) for additional 4 days. FAB did not interfere with the EB mitotic rate of mES cells, as evidenced by similar percentages of mitotic figures labeled by phospho-histone H3 in control (3.4% ± 0.4%) and FAB-treated groups (3.5% ± 1.1%). Nevertheless, the biflavonoid reduced cell death in both control and RA-treated EBs from mES cells by almost 2-fold compared with untreated EBs. FAB was unable, by itself, to induce neuronal differentiation in EBs after 4 days of treatment. On the other hand, FAB enhanced neuronal differentiation induced by RA in both EBs of mES and miPS. FAB increased the percentage of nestin-labeled cells by 2.7-fold (mES) and 2.4 (miPS) and β-tubulin III-positive cells by 2-fold (mES) and 2.7 (miPS) in comparison to RA-treated EBs only. FAB increased the expression of RA receptors α and β in mES EBs, suggesting that the availability of RA receptors is limiting RA-induced neurogenesis in pluripotent stem cells. This is the first report to describe that naturally occurring biflavonoids regulate apoptosis and neuronal differentiation in pluripotent stem cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281018     DOI: 10.1089/scd.2010.0446

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  11 in total

1.  Agathisflavone Modifies Microglial Activation State and Myelination in Organotypic Cerebellar Slices Culture.

Authors:  Monique Marylin Alves de Almeida; Francesca Pieropan; Tim Footz; Jorge Mauricio David; Juceni Pereira David; Victor Diogenes Amaral da Silva; Cleide Dos Santos Souza; Anastassia Voronova; Arthur Morgan Butt; Silvia Lima Costa
Journal:  J Neuroimmune Pharmacol       Date:  2021-04-21       Impact factor: 4.147

Review 2.  Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.

Authors:  Silvia Lima Costa; Victor Diogenes Amaral Silva; Cleide Dos Santos Souza; Cleonice Creusa Santos; Irmgard Paris; Patricia Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2016-03-07       Impact factor: 3.911

3.  Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.

Authors:  Rafaela C Sartore; Priscila B Campos; Cleber A Trujillo; Bia L Ramalho; Priscilla D Negraes; Bruna S Paulsen; Tamara Meletti; Elaine S Costa; Leonardo Chicaybam; Martin H Bonamino; Henning Ulrich; Stevens K Rehen
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

4.  Synchrotron radiation X-ray microfluorescence reveals polarized distribution of atomic elements during differentiation of pluripotent stem cells.

Authors:  Simone C Cardoso; Mariana P Stelling; Bruna S Paulsen; Stevens K Rehen
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

5.  Treatment with retinoic acid and lens epithelial cell-conditioned medium in vitro directed the differentiation of pluripotent stem cells towards corneal endothelial cell-like cells.

Authors:  Ping Chen; Jun-Zhao Chen; Chun-Yi Shao; Chuan-Yin Li; Yi-Dan Zhang; Wen-Juan Lu; Yao Fu; Ping Gu; Xianqun Fan
Journal:  Exp Ther Med       Date:  2014-12-03       Impact factor: 2.447

6.  Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease.

Authors:  Mariana Acquarone; Thiago M de Melo; Fernanda Meireles; Jordano Brito-Moreira; Gabriel Oliveira; Sergio T Ferreira; Newton G Castro; Fernanda Tovar-Moll; Jean-Christophe Houzel; Stevens K Rehen
Journal:  Front Cell Neurosci       Date:  2015-04-08       Impact factor: 5.505

7.  Phytoestrogen Agathisflavone Ameliorates Neuroinflammation-Induced by LPS and IL-1β and Protects Neurons in Cocultures of Glia/Neurons.

Authors:  Monique Marylin Alves de Almeida; Cleide Dos Santos Souza; Naiara Silva Dourado; Alessandra Bispo da Silva; Rafael Short Ferreira; Jorge Mauricio David; Juceni Pereira David; Maria de Fátima Dias Costa; Victor Diógenes Amaral da Silva; Arthur Morgan Butt; Silvia Lima Costa
Journal:  Biomolecules       Date:  2020-04-07

8.  In vitro antioxidant properties of the biflavonoid agathisflavone.

Authors:  Anderson Wilbur Lopes Andrade; Keylla da Conceição Machado; Katia da Conceição Machado; Daiana Dias Ribeiro Figueiredo; Jorge Mauricio David; Muhammad Torequl Islam; Shaikh Jamal Uddin; Jamil A Shilpi; Jéssica Pereira Costa
Journal:  Chem Cent J       Date:  2018-06-29       Impact factor: 4.215

Review 9.  Amburana cearensis: Pharmacological and Neuroprotective Effects of Its Compounds.

Authors:  Juliana Helena Castro E Silva; Rafael Short Ferreira; Erica Patricia Pereira; Suzana Braga-de-Souza; Monique Marylin Alves de Almeida; Cleonice Creusa Dos Santos; Arthur Morgan Butt; Elisabetta Caiazzo; Raffaele Capasso; Victor Diogenes Amaral da Silva; Silvia Lima Costa
Journal:  Molecules       Date:  2020-07-27       Impact factor: 4.411

10.  The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination.

Authors:  Monique Marylin Alves de Almeida; Francesca Pieropan; Larissa de Mattos Oliveira; Manoelito Coelho Dos Santos Junior; Jorge Mauricio David; Juceni Pereira David; Victor Diógenes A da Silva; Cleide Dos Santos Souza; Silvia Lima Costa; Arthur Morgan Butt
Journal:  Pharmacol Res       Date:  2020-06-11       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.